Search results
Found 21865 matches for
A large clinical trial in Africa and Asia has shown that a 7 day course of high dose primaquine, a drug used to treat P. vivax malaria, is well tolerated and just as effective as the current standard 14 day regimen, according to a study published this week in The Lancet. These findings have important implications for the treatment and elimination of vivax malaria in the Asia Pacific.
Brian Angus
BSc, MBChB, DTM&H, FRCP, MD, FFTM Brian Angus - Professor of Practice, Medical Education and Reader in Infectious Diseases
Rose McGready
Rose McGready - Professor of Tropical Maternal and Child Health
Richard Price
Richard Price - Professor of Tropical Medicine
Nicholas White
FRS Nicholas White - Professor of Tropical Medicine
Bridget Wills
Bridget Wills - Professor of Tropical Medicine
Evelyne Kestelyn
Evelyne Kestelyn - Head of the Clinical Trials Unit
Nicholas Day
MA BM BCh DM FRCP FMedSci Nicholas Day - Professor of Tropical Medicine
Mehul Dhorda
Mehul Dhorda - DeTACT-Africa Coordinator / Head of Specimen Management Laboratory
Proochista Ariana
- MSc IHTM Lecturers
- MSc IHTM advisory committee
- MSc IHTM steering committee
- MSc MGH Lecturers
- Principal Investigators
- Research Scientists
Proochista Ariana - Associate Professor
Ronald Geskus
Ronald Geskus - Professor of Medical Statistics
Catherine (Sassy) Molyneux
Catherine (Sassy) Molyneux - Professor of Global Health
Ben Cooper
Ben Cooper - Professor of Epidemiology